Cleared Traditional

K181738 - Medline ReNewal Reprocessed OxiMax Puls...

K181738 is the FDA 510(k) clearance for Medline ReNewal Reprocessed OxiMax Puls... by Surgical Instrument Service and Savings Inc (Dba Medline. It is a Class 2 Anesthesiology device (product code DQA) cleared through the Traditional 510(k) pathway after a 263-day FDA review.

K181738 · Surgical Instrument Service and Savings Inc (Dba Medline · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2019
Decision
263d
Days
Class 2
Risk

K181738 is an FDA 510(k) clearance for the Medline ReNewal Reprocessed OxiMax Pulse Oximetry Sensors. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Surgical Instrument Service and Savings Inc (Dba Medline (Redmond, US). The FDA issued a Cleared decision on March 22, 2019 after a review of 263 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Surgical Instrument Service and Savings Inc (Dba Medline devices

Submission Details

510(k) Number K181738 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 02, 2018
Decision Date March 22, 2019
Days to Decision 263 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
123d slower than avg
Panel avg: 140d · This submission: 263d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 367
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K181738.
Guardian Angel Rx GA2001 Digital Vital Sign Monitoring System
K191207 · Taiwan Aulisa Medical Devices Technologies, Inc. · Jun 2019
SpO2 Sensor
K183277 · Shenzhen Upnmed Equipment Co., Ltd. · May 2019
Loop System
K181352 · Spry Health, Inc. · Mar 2019
Masimo Rad-67 Pulse CO-Oximeter and Accessories
K182887 · Masimo Corporation · Mar 2019
Guardian Angel Rx GA 1001 Digital Vital Sign Monitoring System
K182822 · Taiwan Aulisa Medical Devices Technologies, Inc. · Mar 2019
Guardian Angel Rx GA2000 Digital Vital Sign Monitoring System
K183067 · Taiwan Aulisa Medical Devices Technologies, Inc. · Mar 2019